Prime Medicine Inc [NASDAQ: PRME] jumped around 2149997.84 points on Tuesday, while shares priced at $2150000.0 at the close of the session, up 5712618%.
Prime Medicine Inc stock is now -60.00% down from its year-to-date (YTD) trading value. PRME Stock saw the intraday high of $2.525 and lowest of $2.15 per share. The company’s 52-week high price is 6.75, which means current price is +121.62% above from all time high which was touched on 01/06/25.
Compared to the average trading volume of 2.15M shares, PRME reached a trading volume of 5712618 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Prime Medicine Inc [PRME]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PRME shares is $7.69 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PRME stock is a recommendation set at 1.73. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for Prime Medicine Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on May 27, 2025. The new note on the price target was released on May 20, 2025, representing the official price target for Prime Medicine Inc stock.
The Price to Book ratio for the last quarter was 3.02, with the Price to Cash per share for the same quarter was set at 1.10.
How has PRME stock performed recently?
Prime Medicine Inc [PRME] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 64.00. With this latest performance, PRME shares gained by 100.00% in over the last four-week period, additionally sinking by -6.82% over the last 6 months – not to mention a drop of -15.75% in the past year of trading.
Prime Medicine Inc [PRME]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Prime Medicine Inc [PRME] shares currently have an operating margin of -5369.68% and a Gross Margin at -69.34%. Prime Medicine Inc’s Net Margin is presently recorded at -5252.50%.
Return on Equity for this stock declined to -63.17%, with Return on Assets sitting at -63.17%.
Earnings analysis for Prime Medicine Inc [PRME]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PRME. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Prime Medicine Inc go to 18.30%.
Insider trade positions for Prime Medicine Inc [PRME]
There are presently around $56.84%, or 74.96% of PRME stock, in the hands of institutional investors. The top three institutional holders of PRME stocks are: ALPHABET INC. with ownership of 15.06 million shares, which is approximately 12.6375%. ARK INVESTMENT MANAGEMENT LLC, holding 6.13 million shares of the stock with an approximate value of $$31.49 million in PRME stocks shares; and ARK INVESTMENT MANAGEMENT LLC, currently with $$31.25 million in PRME stock with ownership which is approximately 5.1002%.
